- Home
- MODV vs LYRA Comparison
MODV vs LYRA Comparison
Compare MODV & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODV
- LYRA
- Stock Information
- Founded
- MODV 1996
- LYRA 2005
- Country
- MODV United States
- LYRA United States
- Employees
- MODV N/A
- LYRA 30
- Industry
- MODV Transportation Services
- LYRA Medical/Dental Instruments
- Sector
- MODV Consumer Discretionary
- LYRA Health Care
- Exchange
- MODV Nasdaq
- LYRA Nasdaq
- Market Cap
- MODV 16.1M
- LYRA 15.0M
- IPO Year
- MODV N/A
- LYRA 2020
- Fundamental
- Price
- MODV $3.24
- LYRA $10.65
- Analyst Decision
- MODV Buy
- LYRA Buy
- Analyst Count
- MODV 4
- LYRA 2
- Target Price
- MODV $9.17
- LYRA $16.00
- AVG Volume (30 Days)
- MODV 13.8M
- LYRA 1.9M
- Earning Date
- MODV 08-06-2025
- LYRA 08-13-2025
- Dividend Yield
- MODV N/A
- LYRA N/A
- EPS Growth
- MODV N/A
- LYRA N/A
- EPS
- MODV N/A
- LYRA N/A
- Revenue
- MODV $2,753,789,000.00
- LYRA $1,185,000.00
- Revenue This Year
- MODV N/A
- LYRA N/A
- Revenue Next Year
- MODV $4.90
- LYRA $1,286.17
- P/E Ratio
- MODV N/A
- LYRA N/A
- Revenue Growth
- MODV N/A
- LYRA N/A
- 52 Week Low
- MODV $0.87
- LYRA $3.81
- 52 Week High
- MODV $32.82
- LYRA $37.50
- Technical
- Relative Strength Index (RSI)
- MODV 58.85
- LYRA 48.18
- Support Level
- MODV $2.83
- LYRA $9.81
- Resistance Level
- MODV $3.79
- LYRA $27.42
- Average True Range (ATR)
- MODV 0.90
- LYRA 5.15
- MACD
- MODV 0.04
- LYRA -1.04
- Stochastic Oscillator
- MODV 60.28
- LYRA 7.52
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.